Impacto da vacina pneumocócica conjugada 10-valente (PCV10) na hospitalização de crianças por pneumonia em Goiânia: uso de dados primários e secundários
Ano de defesa: | 2015 |
---|---|
Autor(a) principal: | |
Orientador(a): | |
Banca de defesa: | , , , , |
Tipo de documento: | Tese |
Tipo de acesso: | Acesso aberto |
Idioma: | por |
Instituição de defesa: |
Universidade Federal de Goiás
|
Programa de Pós-Graduação: |
Programa de Pós-graduação em Medicina Tropical e Saúde Publica (IPTSP)
|
Departamento: |
Instituto de Patologia Tropical e Saúde Pública - IPTSP (RG)
|
País: |
Brasil
|
Palavras-chave em Português: | |
Palavras-chave em Inglês: | |
Área do conhecimento CNPq: | |
Link de acesso: | http://repositorio.bc.ufg.br/tede/handle/tede/4885 |
Resumo: | Background. Anticipating the introduction of the 10-valent pneumococcal conjugate vaccine (PCV10) on childhood National Immunization Program (NIP), an active population-based surveillance on pneumonia hospitalizations was conducted as a baseline, enabling a vaccination impact study. The objectives of the present research were: (i) to assess the reliability of the Hospital Information System of the Unified Health System (SIH-SUS) as a data source for assessing PCV10 impact on pneumonia; (ii) to measure the impact of vaccination with PCV10 in reducing the incidence of clinical and X-Ray confirmed pneumonia, in children residing in Goiânia municipality. Methods. In this study, we conducted an active prospective population-based surveillance on pneumonia in the post PCV10 vaccination period (2011-2013), in all 17 pediatric hospitals of Goiânia, with similar methodology used in the previous pneumonia surveillance during the pre vaccination period (2007-2009). Children aged 2-35 months of age, admitted to hospitalization with suspected diagnosis of pneumonia, were elegible for the survey. Clinical pneumonia and X-Ray confirmed pneumonia were the outcomes. The intervention was the PCV10, introduced in June 2010 in Goiania. Probabilistic linkage was performed between the SIH-SUS database (secondary data) and the active population surveillance (primary data) for the year 2012, to measure the agreement of case identification on pneumonia hospitalization rates between both data sources. To assess the impact of PCV10, annual incidence of clinical pneumonia and X-Ray confirmed pneumonia (per 100,000 population) and respective 95% confidence interval (95%CI) was estimated for the post vaccinations period and compared to the rates obtained for the pre vaccination period. The relative risk for pneumonia and respective 95%CI were calculated based on Poisson distribution. The percentage change in rates (1-relative risk) between pre and post vaccination periods was calculated. Results. Pneumonia incidence rates obtained by the SIH-SUS were statistically similar to those obtained by active population surveillance for children 2-23meses (p = 0.184). On the PCV10 impact evaluation study, the rates of hospitalization for clinical and RXT confirmed pneumonia in children under 24 months decreased 13.1% (from 5,728/100,000 to 4,976/100,000) and 25.4% (from 2,497/100,000 to 1,862/100,000), respectively, after routine immunization. |
id |
UFG-2_60ea0bc7a364493e16e188fce908732c |
---|---|
oai_identifier_str |
oai:repositorio.bc.ufg.br:tede/4885 |
network_acronym_str |
UFG-2 |
network_name_str |
Repositório Institucional da UFG |
repository_id_str |
|
spelling |
Andrade, Ana Lúcia Sampaio Sgambatti dehttp://lattes.cnpq.br/7770363683068899Andrade, Ana Lúcia Sampaio Sgambatti deMoraes, Jose Cássio deBerezin, Eitan NaamanSucasas, PauloSiqueira Júnior, João Boscohttp://lattes.cnpq.br/2492187917737135Andrade, Sabrina Sgambatti de2015-11-12T12:21:22Z2015-07-17SGAMBATTI, S. Impacto da vacina pneumocócica conjugada 10-valente (PCV10) na hospitalização de crianças por pneumonia em Goiânia: uso de dados primários e secundários. 2015. 88 f. Tese (Doutorado em Medicina Tropical e Saúde Publica) - Universidade Federal de Goiás, Goiânia, 2015.http://repositorio.bc.ufg.br/tede/handle/tede/4885Background. Anticipating the introduction of the 10-valent pneumococcal conjugate vaccine (PCV10) on childhood National Immunization Program (NIP), an active population-based surveillance on pneumonia hospitalizations was conducted as a baseline, enabling a vaccination impact study. The objectives of the present research were: (i) to assess the reliability of the Hospital Information System of the Unified Health System (SIH-SUS) as a data source for assessing PCV10 impact on pneumonia; (ii) to measure the impact of vaccination with PCV10 in reducing the incidence of clinical and X-Ray confirmed pneumonia, in children residing in Goiânia municipality. Methods. In this study, we conducted an active prospective population-based surveillance on pneumonia in the post PCV10 vaccination period (2011-2013), in all 17 pediatric hospitals of Goiânia, with similar methodology used in the previous pneumonia surveillance during the pre vaccination period (2007-2009). Children aged 2-35 months of age, admitted to hospitalization with suspected diagnosis of pneumonia, were elegible for the survey. Clinical pneumonia and X-Ray confirmed pneumonia were the outcomes. The intervention was the PCV10, introduced in June 2010 in Goiania. Probabilistic linkage was performed between the SIH-SUS database (secondary data) and the active population surveillance (primary data) for the year 2012, to measure the agreement of case identification on pneumonia hospitalization rates between both data sources. To assess the impact of PCV10, annual incidence of clinical pneumonia and X-Ray confirmed pneumonia (per 100,000 population) and respective 95% confidence interval (95%CI) was estimated for the post vaccinations period and compared to the rates obtained for the pre vaccination period. The relative risk for pneumonia and respective 95%CI were calculated based on Poisson distribution. The percentage change in rates (1-relative risk) between pre and post vaccination periods was calculated. Results. Pneumonia incidence rates obtained by the SIH-SUS were statistically similar to those obtained by active population surveillance for children 2-23meses (p = 0.184). On the PCV10 impact evaluation study, the rates of hospitalization for clinical and RXT confirmed pneumonia in children under 24 months decreased 13.1% (from 5,728/100,000 to 4,976/100,000) and 25.4% (from 2,497/100,000 to 1,862/100,000), respectively, after routine immunization.Introdução. Antecipando a introdução da vacina pneumocócica conjugada 10-valente (PCV10) no calendário de vacinação infantil do Programa Nacional de Imunizações (PNI), um estudo de vigilância de base populacional ativa foi conduzido como linha de base, possibilitando, assim, avaliar o impacto da vacinação nas hospitalizações por pneumonia. Assim, os objetivos desta investigação foram: (i) avaliar a confiabilidade do Sistema de Informações Hospitalares do Sistema Único de Saúde (SIH-SUS) como fonte de dados para estudos de avaliação de impacto da PCV10 nas pneumonias; (ii) avaliar o impacto da vacinação com a PCV10 na redução da incidência de hospitalizações de crianças com pneumonia clínica e confirmada por Raio-X de tórax (RXT), residentes no município de Goiânia. Métodos. Neste estudo, conduzimos uma vigilância populacional prospectiva, ativa, de pneumonias no período pós vacinal (2011-2013) em 17 hospitais pediátricos de Goiânia, com metodologia similar à conduzida em estudo anterior, no período pré vacinal (2007-2009). Foram elegíveis para o estudo crianças de 2 a 35 meses de idade, admitidas com com diagnóstico inicial de pneumonia. Os desfechos foram pneumonia clínica e pneumonia confirmada por RXT. A intervenção foi a PCV10, introduzida em junho de 2010 em Goiânia. A técnica de linkage probabilístico foi utilizada para vincular o banco de dados do SIH-SUS (dados secundários) e o da vigilância populacional ativa (dados primários) referentes ao ano de 2012, e desta forma, avaliar a concordância no diagnóstico e nas taxas de hospitalização por pneumonia entre as duas fontes de dados. Para avaliar o impacto da PCV10, calculou-se a incidência anual de pneumonia clínica e confirmada por RXT (por 100.000 habitantes) e respectivos intervalos de 95% de confiança (IC95%) para o período pós vacinal, e comparou-se com as taxas do período pré vacinal. O risco relativo para pneumonia e respectivos IC95% foram calculados com base na distribuição de Poisson. O percentual de mudança entre as taxas pré e pós vacinal foi calculado como 1-risco relativo. Resultados. As taxas de pneumonia obtidas pelo SIH-SUS foram estatisticamente similares às obtidas por vigilância populacional ativa para as crianças de 2-23meses (p=0,184). No estudo de avaliação do impacto da PCV10, as taxas de hospitalização por pneumonia clínica e confirmada por RXT em crianças menores de 24 meses reduziram 13.1% (de 5,728/100,000 para 4,976/100,000) e 25.4% (de 2,497/100,000 para 1,862/100,000), respectivamente, após a vacinação de rotina. Conclusões. Dados do SIH-SUS podem ser utilizados para avaliar o impacto da PCV10 nas hospilazações por pneumonia na infância. Após 3 anos de vacinação com a PCV10 em Goiânia, observou-se significante queda das taxas de hospitalização por pneumonia clinica e confirmada por RXT em crianças alvo do PNI.Submitted by Cássia Santos (cassia.bcufg@gmail.com) on 2015-11-12T12:16:48Z No. of bitstreams: 2 Tese - Sabrina Sgambatti - 2015.pdf: 2847998 bytes, checksum: 069ae0ef61790cc3dd2564c3e7fa9120 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)Approved for entry into archive by Luciana Ferreira (lucgeral@gmail.com) on 2015-11-12T12:21:22Z (GMT) No. of bitstreams: 2 Tese - Sabrina Sgambatti - 2015.pdf: 2847998 bytes, checksum: 069ae0ef61790cc3dd2564c3e7fa9120 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5)Made available in DSpace on 2015-11-12T12:21:22Z (GMT). No. of bitstreams: 2 Tese - Sabrina Sgambatti - 2015.pdf: 2847998 bytes, checksum: 069ae0ef61790cc3dd2564c3e7fa9120 (MD5) license_rdf: 23148 bytes, checksum: 9da0b6dfac957114c6a7714714b86306 (MD5) Previous issue date: 2015-07-17application/pdfhttp://repositorio.bc.ufg.br/tede/retrieve/22682/Tese%20-%20Sabrina%20Sgambatti%20-%202015.pdf.jpgporUniversidade Federal de GoiásPrograma de Pós-graduação em Medicina Tropical e Saúde Publica (IPTSP)UFGBrasilInstituto de Patologia Tropical e Saúde Pública - IPTSP (RG)http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessStreptococcus pneumoniaeVigilância de base populacionalPneumoniaPneumonia adquirida na comunidadeVigilância de pneumoniaVacina pneumocócica conjugadaVacina pneumocócica conjugada 10-valenteImpacto de vacinasInfânciaCriançasStreptococcus pneumoniaeCommunity-acquired pneumoniaPneumococcal conjugate vaccine10-valent pneumococcal conjugate vaccinePopulation-based surveillancePneumonia surveillanceVaccine impactChildrenCLINICA MEDICA::DOENCAS INFECCIOSAS E PARASITARIASImpacto da vacina pneumocócica conjugada 10-valente (PCV10) na hospitalização de crianças por pneumonia em Goiânia: uso de dados primários e secundáriosAssessing PCV10 impact in children hospitalized with pneumonia in Goiânia: using primary and secondary datainfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesis6085308344741430434600600600-77690114445645562881767748423488408711reponame:Repositório Institucional da UFGinstname:Universidade Federal de Goiás (UFG)instacron:UFGLICENSElicense.txtlicense.txttext/plain; charset=utf-82165http://repositorio.bc.ufg.br/tede/bitstreams/763203e9-c873-417d-97b1-8ab4d03d0c09/downloadbd3efa91386c1718a7f26a329fdcb468MD51CC-LICENSElicense_urllicense_urltext/plain; charset=utf-849http://repositorio.bc.ufg.br/tede/bitstreams/bb39236c-f40f-4253-9e22-24363156558e/download4afdbb8c545fd630ea7db775da747b2fMD52license_textlicense_texttext/html; charset=utf-821468http://repositorio.bc.ufg.br/tede/bitstreams/4fb26c4a-4307-4890-9546-cc721c31682a/downloadae2fe251842ade1134c5d9bb99b6eefeMD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-823148http://repositorio.bc.ufg.br/tede/bitstreams/048a5de0-11ba-45e5-924a-0f08e5d4e05c/download9da0b6dfac957114c6a7714714b86306MD54ORIGINALTese - Sabrina Sgambatti - 2015.pdfTese - Sabrina Sgambatti - 2015.pdfapplication/pdf2847998http://repositorio.bc.ufg.br/tede/bitstreams/84e545a4-fe7e-4cec-a5a6-5b9a2068f220/download069ae0ef61790cc3dd2564c3e7fa9120MD55TEXTTese - Sabrina Sgambatti - 2015.pdf.txtTese - Sabrina Sgambatti - 2015.pdf.txtExtracted Texttext/plain165130http://repositorio.bc.ufg.br/tede/bitstreams/e7ad90fc-6c2d-4257-a59f-0473808a2679/downloadbb3e00eeb4b699045e507d6682eb979bMD56THUMBNAILTese - Sabrina Sgambatti - 2015.pdf.jpgTese - Sabrina Sgambatti - 2015.pdf.jpgGenerated Thumbnailimage/jpeg2157http://repositorio.bc.ufg.br/tede/bitstreams/f7637d78-282e-4b71-959b-b2e96bfe7ca7/downloadcf4c2749064c2c89bc0f8d6783646cafMD57tede/48852017-09-15 18:22:48.133http://creativecommons.org/licenses/by-nc-nd/4.0/Acesso Abertoopen.accessoai:repositorio.bc.ufg.br:tede/4885http://repositorio.bc.ufg.br/tedeRepositório InstitucionalPUBhttp://repositorio.bc.ufg.br/oai/requesttasesdissertacoes.bc@ufg.bropendoar:2017-09-15T21:22:48Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)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 |
dc.title.por.fl_str_mv |
Impacto da vacina pneumocócica conjugada 10-valente (PCV10) na hospitalização de crianças por pneumonia em Goiânia: uso de dados primários e secundários |
dc.title.alternative.eng.fl_str_mv |
Assessing PCV10 impact in children hospitalized with pneumonia in Goiânia: using primary and secondary data |
title |
Impacto da vacina pneumocócica conjugada 10-valente (PCV10) na hospitalização de crianças por pneumonia em Goiânia: uso de dados primários e secundários |
spellingShingle |
Impacto da vacina pneumocócica conjugada 10-valente (PCV10) na hospitalização de crianças por pneumonia em Goiânia: uso de dados primários e secundários Andrade, Sabrina Sgambatti de Streptococcus pneumoniae Vigilância de base populacional Pneumonia Pneumonia adquirida na comunidade Vigilância de pneumonia Vacina pneumocócica conjugada Vacina pneumocócica conjugada 10-valente Impacto de vacinas Infância Crianças Streptococcus pneumoniae Community-acquired pneumonia Pneumococcal conjugate vaccine 10-valent pneumococcal conjugate vaccine Population-based surveillance Pneumonia surveillance Vaccine impact Children CLINICA MEDICA::DOENCAS INFECCIOSAS E PARASITARIAS |
title_short |
Impacto da vacina pneumocócica conjugada 10-valente (PCV10) na hospitalização de crianças por pneumonia em Goiânia: uso de dados primários e secundários |
title_full |
Impacto da vacina pneumocócica conjugada 10-valente (PCV10) na hospitalização de crianças por pneumonia em Goiânia: uso de dados primários e secundários |
title_fullStr |
Impacto da vacina pneumocócica conjugada 10-valente (PCV10) na hospitalização de crianças por pneumonia em Goiânia: uso de dados primários e secundários |
title_full_unstemmed |
Impacto da vacina pneumocócica conjugada 10-valente (PCV10) na hospitalização de crianças por pneumonia em Goiânia: uso de dados primários e secundários |
title_sort |
Impacto da vacina pneumocócica conjugada 10-valente (PCV10) na hospitalização de crianças por pneumonia em Goiânia: uso de dados primários e secundários |
author |
Andrade, Sabrina Sgambatti de |
author_facet |
Andrade, Sabrina Sgambatti de |
author_role |
author |
dc.contributor.advisor1.fl_str_mv |
Andrade, Ana Lúcia Sampaio Sgambatti de |
dc.contributor.advisor1Lattes.fl_str_mv |
http://lattes.cnpq.br/7770363683068899 |
dc.contributor.referee1.fl_str_mv |
Andrade, Ana Lúcia Sampaio Sgambatti de |
dc.contributor.referee2.fl_str_mv |
Moraes, Jose Cássio de |
dc.contributor.referee3.fl_str_mv |
Berezin, Eitan Naaman |
dc.contributor.referee4.fl_str_mv |
Sucasas, Paulo |
dc.contributor.referee5.fl_str_mv |
Siqueira Júnior, João Bosco |
dc.contributor.authorLattes.fl_str_mv |
http://lattes.cnpq.br/2492187917737135 |
dc.contributor.author.fl_str_mv |
Andrade, Sabrina Sgambatti de |
contributor_str_mv |
Andrade, Ana Lúcia Sampaio Sgambatti de Andrade, Ana Lúcia Sampaio Sgambatti de Moraes, Jose Cássio de Berezin, Eitan Naaman Sucasas, Paulo Siqueira Júnior, João Bosco |
dc.subject.por.fl_str_mv |
Streptococcus pneumoniae Vigilância de base populacional Pneumonia Pneumonia adquirida na comunidade Vigilância de pneumonia Vacina pneumocócica conjugada Vacina pneumocócica conjugada 10-valente Impacto de vacinas Infância Crianças |
topic |
Streptococcus pneumoniae Vigilância de base populacional Pneumonia Pneumonia adquirida na comunidade Vigilância de pneumonia Vacina pneumocócica conjugada Vacina pneumocócica conjugada 10-valente Impacto de vacinas Infância Crianças Streptococcus pneumoniae Community-acquired pneumonia Pneumococcal conjugate vaccine 10-valent pneumococcal conjugate vaccine Population-based surveillance Pneumonia surveillance Vaccine impact Children CLINICA MEDICA::DOENCAS INFECCIOSAS E PARASITARIAS |
dc.subject.eng.fl_str_mv |
Streptococcus pneumoniae Community-acquired pneumonia Pneumococcal conjugate vaccine 10-valent pneumococcal conjugate vaccine Population-based surveillance Pneumonia surveillance Vaccine impact Children |
dc.subject.cnpq.fl_str_mv |
CLINICA MEDICA::DOENCAS INFECCIOSAS E PARASITARIAS |
description |
Background. Anticipating the introduction of the 10-valent pneumococcal conjugate vaccine (PCV10) on childhood National Immunization Program (NIP), an active population-based surveillance on pneumonia hospitalizations was conducted as a baseline, enabling a vaccination impact study. The objectives of the present research were: (i) to assess the reliability of the Hospital Information System of the Unified Health System (SIH-SUS) as a data source for assessing PCV10 impact on pneumonia; (ii) to measure the impact of vaccination with PCV10 in reducing the incidence of clinical and X-Ray confirmed pneumonia, in children residing in Goiânia municipality. Methods. In this study, we conducted an active prospective population-based surveillance on pneumonia in the post PCV10 vaccination period (2011-2013), in all 17 pediatric hospitals of Goiânia, with similar methodology used in the previous pneumonia surveillance during the pre vaccination period (2007-2009). Children aged 2-35 months of age, admitted to hospitalization with suspected diagnosis of pneumonia, were elegible for the survey. Clinical pneumonia and X-Ray confirmed pneumonia were the outcomes. The intervention was the PCV10, introduced in June 2010 in Goiania. Probabilistic linkage was performed between the SIH-SUS database (secondary data) and the active population surveillance (primary data) for the year 2012, to measure the agreement of case identification on pneumonia hospitalization rates between both data sources. To assess the impact of PCV10, annual incidence of clinical pneumonia and X-Ray confirmed pneumonia (per 100,000 population) and respective 95% confidence interval (95%CI) was estimated for the post vaccinations period and compared to the rates obtained for the pre vaccination period. The relative risk for pneumonia and respective 95%CI were calculated based on Poisson distribution. The percentage change in rates (1-relative risk) between pre and post vaccination periods was calculated. Results. Pneumonia incidence rates obtained by the SIH-SUS were statistically similar to those obtained by active population surveillance for children 2-23meses (p = 0.184). On the PCV10 impact evaluation study, the rates of hospitalization for clinical and RXT confirmed pneumonia in children under 24 months decreased 13.1% (from 5,728/100,000 to 4,976/100,000) and 25.4% (from 2,497/100,000 to 1,862/100,000), respectively, after routine immunization. |
publishDate |
2015 |
dc.date.accessioned.fl_str_mv |
2015-11-12T12:21:22Z |
dc.date.issued.fl_str_mv |
2015-07-17 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/doctoralThesis |
format |
doctoralThesis |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
SGAMBATTI, S. Impacto da vacina pneumocócica conjugada 10-valente (PCV10) na hospitalização de crianças por pneumonia em Goiânia: uso de dados primários e secundários. 2015. 88 f. Tese (Doutorado em Medicina Tropical e Saúde Publica) - Universidade Federal de Goiás, Goiânia, 2015. |
dc.identifier.uri.fl_str_mv |
http://repositorio.bc.ufg.br/tede/handle/tede/4885 |
identifier_str_mv |
SGAMBATTI, S. Impacto da vacina pneumocócica conjugada 10-valente (PCV10) na hospitalização de crianças por pneumonia em Goiânia: uso de dados primários e secundários. 2015. 88 f. Tese (Doutorado em Medicina Tropical e Saúde Publica) - Universidade Federal de Goiás, Goiânia, 2015. |
url |
http://repositorio.bc.ufg.br/tede/handle/tede/4885 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.program.fl_str_mv |
6085308344741430434 |
dc.relation.confidence.fl_str_mv |
600 600 600 |
dc.relation.department.fl_str_mv |
-7769011444564556288 |
dc.relation.cnpq.fl_str_mv |
1767748423488408711 |
dc.rights.driver.fl_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-nd/4.0/ |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade Federal de Goiás |
dc.publisher.program.fl_str_mv |
Programa de Pós-graduação em Medicina Tropical e Saúde Publica (IPTSP) |
dc.publisher.initials.fl_str_mv |
UFG |
dc.publisher.country.fl_str_mv |
Brasil |
dc.publisher.department.fl_str_mv |
Instituto de Patologia Tropical e Saúde Pública - IPTSP (RG) |
publisher.none.fl_str_mv |
Universidade Federal de Goiás |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFG instname:Universidade Federal de Goiás (UFG) instacron:UFG |
instname_str |
Universidade Federal de Goiás (UFG) |
instacron_str |
UFG |
institution |
UFG |
reponame_str |
Repositório Institucional da UFG |
collection |
Repositório Institucional da UFG |
bitstream.url.fl_str_mv |
http://repositorio.bc.ufg.br/tede/bitstreams/763203e9-c873-417d-97b1-8ab4d03d0c09/download http://repositorio.bc.ufg.br/tede/bitstreams/bb39236c-f40f-4253-9e22-24363156558e/download http://repositorio.bc.ufg.br/tede/bitstreams/4fb26c4a-4307-4890-9546-cc721c31682a/download http://repositorio.bc.ufg.br/tede/bitstreams/048a5de0-11ba-45e5-924a-0f08e5d4e05c/download http://repositorio.bc.ufg.br/tede/bitstreams/84e545a4-fe7e-4cec-a5a6-5b9a2068f220/download http://repositorio.bc.ufg.br/tede/bitstreams/e7ad90fc-6c2d-4257-a59f-0473808a2679/download http://repositorio.bc.ufg.br/tede/bitstreams/f7637d78-282e-4b71-959b-b2e96bfe7ca7/download |
bitstream.checksum.fl_str_mv |
bd3efa91386c1718a7f26a329fdcb468 4afdbb8c545fd630ea7db775da747b2f ae2fe251842ade1134c5d9bb99b6eefe 9da0b6dfac957114c6a7714714b86306 069ae0ef61790cc3dd2564c3e7fa9120 bb3e00eeb4b699045e507d6682eb979b cf4c2749064c2c89bc0f8d6783646caf |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFG - Universidade Federal de Goiás (UFG) |
repository.mail.fl_str_mv |
tasesdissertacoes.bc@ufg.br |
_version_ |
1798044957182787584 |